Search

everythinglearnresearchcommunity

for

Search:↓

High blood pressure drugs often cause skin lupus, stopping the drug usually helps. A vaccine helps prevent genital herpes and HPV-16. More frequent light therapy clears psoriasis faster. No link was found between low iron and chronic hair loss.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

Female hair loss can be diagnosed using specific trichoscopy criteria.

Abnormal growth factor metabolism may link psoriasis and metabolic syndrome, and obesity can affect psoriasis treatment effectiveness.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

The DLQI is a key tool for measuring quality of life in dermatology.

Systemic therapies improve nail psoriasis but have high side effects; more research is needed.

Severe alopecia areata may increase the risk of heart-related diseases.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

There is a significant need for better-validated quality of life tools in dermatology.

Psoriasis patients have different skin bacteria, which may cause flare-ups.

Cal/BD aerosol foam effectively treats scalp psoriasis, improving symptoms and patient satisfaction.

Targeting CD169+ skin macrophages may help treat psoriasis.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

The Pfizer COVID-19 vaccine may rarely trigger nail psoriasis.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

The CWARTS tool is a promising method for assessing warts and could improve treatment and research.

Vitamin D3 deficiency can worsen psoriasis by promoting Candida overgrowth.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.